Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study
被引:2
|
作者:
Kunitoh, H
论文数: 0引用数: 0
h-index: 0
机构:
E Japan Lunc Canc CPT 11 Study Grp, Tokyo, JapanE Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan
Kunitoh, H
[1
]
Saijo, N
论文数: 0引用数: 0
h-index: 0
机构:
E Japan Lunc Canc CPT 11 Study Grp, Tokyo, JapanE Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan
Saijo, N
[1
]
Nagao, K
论文数: 0引用数: 0
h-index: 0
机构:
E Japan Lunc Canc CPT 11 Study Grp, Tokyo, JapanE Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan
Nagao, K
[1
]
Ohashi, Y
论文数: 0引用数: 0
h-index: 0
机构:
E Japan Lunc Canc CPT 11 Study Grp, Tokyo, JapanE Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan
Ohashi, Y
[1
]
Niitani, H
论文数: 0引用数: 0
h-index: 0
机构:
E Japan Lunc Canc CPT 11 Study Grp, Tokyo, JapanE Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan
Niitani, H
[1
]
机构:
[1] E Japan Lunc Canc CPT 11 Study Grp, Tokyo, Japan